Affiliate disclosure: this article contains Amazon affiliate links. As an Amazon Associate, this site earns from qualifying purchases at no extra cost to you.
Most ashwagandha content aimed at women focuses on perimenopause, the transitional years typically in the 40s when hormone levels fluctuate the most. Less gets written about women past menopause, generally defined as 12 months without a period[1], whose bodies and priorities have shifted again. This article looks at what is different about using ashwagandha after 60, rather than assuming the perimenopause guidance applies unchanged.
How the Symptom Picture Shifts After Menopause
By the postmenopausal years, estrogen levels have stabilized at a consistently lower baseline rather than fluctuating unpredictably, which means some perimenopause symptoms driven specifically by hormonal swings, like unpredictable hot flash timing tied to cycle changes, may settle into a more consistent pattern or diminish for some women. What often remains, and sometimes becomes more prominent, are age-related concerns like bone density, muscle mass maintenance, sleep quality, and stress resilience, areas where ashwagandha’s studied effects are still potentially relevant but for somewhat different reasons than in the 40s.
What the Research Population Actually Looks Like
It is worth being direct about a limitation, and being specific about its shape. Most ashwagandha trials, including the ones most frequently cited for stress and sleep, enrolled adults broadly. Trials dedicated to menopausal women do exist, but they stop short of this age group: a randomised placebo-controlled trial of ashwagandha root extract for menopausal symptoms enrolled women aged 45 to 55[2], and a postmenopausal trial tracking menopause scores, vascular measures and bone turnover enrolled women aged 40 to 55[3].
So the gap is specific rather than total. Dedicated postmenopausal evidence does exist, but it was not gathered above roughly age 55, and carrying its dosing and safety profile past 60 is still extrapolation.
Medication Interactions Become More Relevant With Age
Polypharmacy, taking multiple prescription medications simultaneously, becomes more common with age, and this raises the practical importance of checking ashwagandha against a woman’s full medication list rather than just the medication classes most often mentioned in supplement content.
Thyroid medication, blood pressure medication, blood thinners, sedatives, and diabetes medication are all worth specifically reviewing with a doctor or pharmacist before starting ashwagandha in this age group, since the cumulative interaction risk across multiple medications is harder to predict than with a single drug in isolation. A recent critical review of ashwagandha’s adverse effects makes the same point from the other direction, identifying endocrine and hepatic effects and specific populations at raised risk of interactions with prescribed drugs[4].
Bone Density and Muscle Mass Considerations
Some preliminary research has examined ashwagandha’s relationship to muscle strength and recovery, but the trial most often cited for it enrolled men aged 18 to 50 doing resistance training[5], which is not this article’s readership. On bone, the closest evidence is the postmenopausal trial above, which reported reduced bone turnover markers over 24 weeks[3].
Those are biochemical markers of bone remodelling, not a measured change in bone mineral density, and they were recorded in women aged 40 to 55. Neither line of research establishes a bone-density benefit for a woman over 60. Women over 60 focused on bone health and sarcopenia prevention should treat ashwagandha as, at most, a general stress-support supplement alongside established interventions like resistance training, adequate protein and calcium intake, and vitamin D, not as a primary bone or muscle strategy.
Starting Conservatively at This Life Stage
Starting at the lower end of the studied dose range, generally around 300 milligrams of standardized extract daily, and observing for several weeks before considering an increase is a reasonable, cautious approach for women over 60, particularly those new to ashwagandha or taking other medications. A standardized ashwagandha root extract capsule with a clearly labeled milligram dose makes it easier to start low and adjust deliberately than a powder that requires measuring.
When to Involve a Doctor Before Starting
Women over 60 with thyroid conditions, autoimmune disease, a history of liver problems, or those taking five or more regular medications should talk with a doctor before starting ashwagandha, not because it is necessarily unsafe, but because the interaction and monitoring considerations are more complex than for a younger, healthier population.
Frequently Asked Questions
Does ashwagandha work differently after menopause than during perimenopause?
The underlying mechanism is the same, but the symptom picture shifts as hormones stabilize at a lower baseline, so the reasons a postmenopausal woman might use it can differ from a perimenopausal woman’s reasons.
Were postmenopausal women included in the major ashwagandha trials?
Yes, but not women over 60. Trials dedicated to menopausal and postmenopausal women enrolled participants aged roughly 40 to 55, so guidance for women over 60 still involves extrapolation from a younger group.
Is ashwagandha riskier for women on multiple medications?
The interaction risk itself does not necessarily increase, but the practical importance of reviewing the full medication list with a doctor increases as the number of medications increases.
Should a woman over 60 start at the same dose as a younger woman?
Starting at the lower end of the studied range and increasing gradually if needed is a reasonable, cautious approach, particularly for anyone new to ashwagandha or on other medications.
References
- Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab, 2012
- A prospective, randomized, double-blind, placebo-controlled study on efficacy and safety of Ashwagandha root extract (Withania somnifera) for managing menopausal symptoms in women. Front Reprod Health, 2025
- Ashwagandha and Shatavari Extracts Dose-Dependently Reduce Menopause Symptoms, Vascular Dysfunction, and Bone Resorption in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Study. J Menopausal Med, 2025
- Potential Adverse Effects of Ashwagandha: A Critical Review of Preclinical and Clinical Evidence. Phytother Res, 2026
- Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. J Int Soc Sports Nutr, 2015
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.


